Ambrisentan response in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) - A subgroup analysis of the ARIES-E clinical trial. [electronic resource]
Producer: 20171227Description: 254-63 p. digitalISSN:- 1532-3064
- Adult
- Aged
- Antihypertensive Agents -- administration & dosage
- Connective Tissue Diseases -- complications
- Double-Blind Method
- Endothelin A Receptor Antagonists -- pharmacology
- Female
- Humans
- Hypertension, Pulmonary -- complications
- Male
- Middle Aged
- Outcome Assessment, Health Care
- Phenylpropionates -- administration & dosage
- Predictive Value of Tests
- Prevalence
- Pyridazines -- administration & dosage
- Survival Analysis
- Treatment Outcome
- Walk Test -- methods
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.